INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Clinical trial NCT04908215 · COMPLETED

Trial details

NCT number: NCT04908215
Sponsor: InMed Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex Epidermolysis Bullosa, Junctional Epidermolysis Bullosa Dystrophica Kindler Syndrome

Start date: 2021-12-28
Primary completion: 2023-04-03
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.